
Analysts Viewpoint
ARQT (Arcutis Biotherapeutics Inc) may reap gains as insiders became active recently
Arcutis Biotherapeutics Inc’s filing revealed that its Director Welgus Howard G. unloaded Company’s shares for reported $0.13 million on Jul